BioGaia AB
Biotechnology ResearchStockholm, Sweden51-200 Employees
BioGaia AB is a Swedish biotechnology company specializing in probiotics, with more than three decades of microbiome research. It develops, manufactures, markets, and sells probiotic products for gut health, oral health, and immune health. Its probiotic offerings are based on L. reuteri bacterial strains, and these products are among the most scientifically documented in the field. Its products are distributed through its own subsidiaries or distribution partners in more than 100 countries, and the company is headquartered in Stockholm, Sweden. Its Class B shares trade on the Mid Cap segment of the Nordic Exchange in Stockholm; in late 2025 the group expanded its offices to Australia and New Zealand, widening its footprint in Oceania.